Photo credits: nypost.com
Blood plasma transfusions with high concentrations of COVID-19 antibodies reduced deaths among some virus patients, according to a new study conducted by Mayo Clinic researchers, lending credibility to one of the few known treatments for the illness.
“Early administration of high-titer convalescent plasma against SARS-CoV-2 to mildly ill infected older adults reduced the progression of Covid-19,” the researchers concluded.
For the full story click here.